17 mayo 2015
Results from clinical trials show that a new combination of medications can successfully treat the underlying cause of cystic fibrosis for patients 12 and older with two copies of the F508del gene mutation — the most common form of the life-threatening, genetic disease found in over half of the CF population.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/SwDWpG1y6uo/150517143358.htm
